Mycobacterium tuberculosis Hip1 Dampens Macrophage Proinflammatory Responses by Limiting Toll-Like Receptor 2 Activation
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mycobacterium tuberculosis Hip1 Dampens Macrophage Proinflammatory Responses by Limiting Toll-Like Receptor 2 Activation
Authors
Keywords
-
Journal
INFECTION AND IMMUNITY
Volume 79, Issue 12, Pages 4828-4838
Publisher
American Society for Microbiology
Online
2011-09-27
DOI
10.1128/iai.05574-11
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Innate Immune Recognition ofMycobacterium tuberculosis
- (2011) Johanneke Kleinnijenhuis et al. Clinical & Developmental Immunology
- Human Macrophage Responses to Clinical Isolates from the Mycobacterium tuberculosis Complex Discriminate between Ancient and Modern Lineages
- (2011) Damien Portevin et al. PLoS Pathogens
- Mycobacterium tuberculosis protein ESAT-6 is a potent activator of the NLRP3/ASC inflammasome
- (2010) Bibhuti B. Mishra et al. CELLULAR MICROBIOLOGY
- Cutting Edge: Caspase-1 Independent IL-1 Production Is Critical for Host Resistance to Mycobacterium tuberculosis and Does Not Require TLR Signaling In Vivo
- (2010) K. D. Mayer-Barber et al. JOURNAL OF IMMUNOLOGY
- Regulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptors
- (2010) Clifford V. Harding et al. NATURE REVIEWS MICROBIOLOGY
- Granuloma Formation and Host Defense in Chronic Mycobacterium tuberculosis Infection Requires PYCARD/ASC but Not NLRP3 or Caspase-1
- (2010) Erin McElvania TeKippe et al. PLoS One
- Innate Immune Response to Mycobacterium tuberculosis Beijing and Other Genotypes
- (2010) Chongzhen Wang et al. PLoS One
- Cell-Mediated Immune Responses in Tuberculosis
- (2009) Andrea M. Cooper Annual Review of Immunology
- Immunological and Inflammatory Functions of the Interleukin-1 Family
- (2009) Charles A. Dinarello Annual Review of Immunology
- Mycobacterial survival strategies in the phagosome: defence against host stresses
- (2009) Sabine Ehrt et al. CELLULAR MICROBIOLOGY
- Transcriptional and inflammasome-mediated pathways for the induction of IL-1β production byMycobacterium tuberculosis
- (2009) Johanneke Kleinnijenhuis et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Antimicrobial mechanisms of phagocytes and bacterial evasion strategies
- (2009) Ronald S. Flannagan et al. NATURE REVIEWS MICROBIOLOGY
- Reduced TNF-α and IFN-γ responses to Central Asian strain 1 and Beijing isolates of Mycobacterium tuberculosis in comparison with H37Rv strain
- (2009) Mahnaz Tanveer et al. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
- TLR9 as a key receptor for the recognition of DNA☆
- (2008) Y KUMAGAI et al. ADVANCED DRUG DELIVERY REVIEWS
- Mycobacterium tuberculosis Prevents Inflammasome Activation
- (2008) Sharon S. Master et al. Cell Host & Microbe
- ESX-1-dependent cytolysis in lysosome secretion and inflammasome activation during mycobacterial infection
- (2008) Ingrid C. Koo et al. CELLULAR MICROBIOLOGY
- Containment of aerogenicMycobacterium tuberculosis infection in mice does not require MyD88 adaptor function for TLR2, -4 and -9
- (2008) Christoph Hölscher et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Acid-Susceptible Mutants of Mycobacterium tuberculosis Share Hypersusceptibility to Cell Wall and Oxidative Stress and to the Host Environment
- (2008) O. H. Vandal et al. JOURNAL OF BACTERIOLOGY
- A membrane protein preserves intrabacterial pH in intraphagosomal Mycobacterium tuberculosis
- (2008) Omar H Vandal et al. NATURE MEDICINE
- Mycobacterium tuberculosis Rv2224c modulates innate immune responses
- (2008) J. Rengarajan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now